Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to confirm the safety and efficacy of high-dose Melphalan HCL
for Injection (Propylene Glycol-Free) as a myeloablative conditioning regimen in multiple
myeloma patients (MM) undergoing autologous transplantation.